Regulus Therapeutics Inc. (RGLS) was a big mover last session with its shares rising nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the past one month’s volatile price range of $6.56 to $7.76.
This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t remained in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Regulus currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks worth considering in the Med-Drugs industry are Lannett Company, Inc. (LCI), Zogenix, Inc. (ZGNX) and Sagent Pharmaceuticals, Inc. (SGNT). While LCI sports a Zacks Rank #1 (Strong Buy), ZGNX and SGNT carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment